Should you buy these stocks too? What would it take to make you feel wealthy? Join the NASDAQ Community today and get free, instant access to portfolios, stock ratings, real-time alerts, and more! For the details of Spears Abacus Advisors LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Spears+Abacus+Advisors+LLC Spears Abacus Advisors LLC initiated holdings in iShares Nasdaq Biotechnology Index Fund. The purchase prices were between $246.87 and $293.09, with an estimated average price of $273.18. The stock is now traded at around $286.20. The impact to the portfolio due to this purchase was 0.16%. The holdings were 4,768 shares as of 2016-12-31. Spears Abacus Advisors LLC initiated holdings in Kellogg Co. The purchase prices were between $70.96 and $77.25, with an estimated average price of $74.06. The stock is now traded at around $75.52. The impact to the portfolio due to this purchase was 0.09%. The holdings were 9,157 shares as of 2016-12-31. Spears Abacus Advisors LLC initiated holdings in Kimberly-Clark Corp. The purchase prices were between $112.15 and $124.76, with an estimated average price of $116.08. The stock is now traded at around $123.51. The impact to the portfolio due to this purchase was 0.08%. The holdings were 5,295 shares as of 2016-12-31. Spears Abacus Advisors LLC initiated holdings in Great Plains Energy Inc. The purchase prices were between $26.2 and $28.6, with an estimated average price of $27.33. The stock is now traded at around $27.94. The impact to the portfolio due to this purchase was 0.07%. The holdings were 20,198 shares as of 2016-12-31. Spears Abacus Advisors LLC initiated holdings in Mead Johnson Nutrition Co. The purchase prices were between $70.69 and $80.96, with an estimated average price of $74.53. The stock is now traded at around $88.08. The impact to the portfolio due to this purchase was 0.07%. The holdings were 7,832 shares as of 2016-12-31. Spears Abacus Advisors LLC initiated holdings in Viacom Inc. The purchase prices were between $34.49 and $38.86, with an estimated average price of $36.74. The stock is now traded at around $43.31. The impact to the portfolio due to this purchase was 0.04%. The holdings were 7,968 shares as of 2016-12-31. Spears Abacus Advisors LLC added to the holdings in The Hershey Co by 239.15%. The purchase prices were between $94.63 and $104.44, with an estimated average price of $98.75. The stock is now traded at around $108.13. The impact to the portfolio due to this purchase was 0.07%. The holdings were 7,719 shares as of 2016-12-31. Spears Abacus Advisors LLC sold out the holdings in Robert Half International Inc. The sale prices were between $36.7 and $49.24, with an estimated average price of $42.83. Spears Abacus Advisors LLC sold out the holdings in Abbott Laboratories. The sale prices were between $37.6 and $43.5, with an estimated average price of $39.65. Spears Abacus Advisors LLC sold out the holdings in Norwegian Cruise Line Holdings Ltd. The sale prices were between $35.53 and $45.14, with an estimated average price of $40.03. Spears Abacus Advisors LLC sold out the holdings in Royal Caribbean Cruises Ltd. The sale prices were between $68.05 and $86.19, with an estimated average price of $78.71. Spears Abacus Advisors LLC sold out the holdings in America Movil SAB de CV. The sale prices were between $11.25 and $13.39, with an estimated average price of $12.11. Spears Abacus Advisors LLC sold out the holdings in Bed Bath Beyond Inc. The sale prices were between $38.67 and $48.08, with an estimated average price of $43.37. Spears Abacus Advisors LLC reduced to the holdings in Allergan PLC by 26.75%. The sale prices were between $188.47 and $242.65, with an estimated average price of $207.16. The stock is now traded at around $247.86. The impact to the portfolio due to this sale was -1.08%. Spears Abacus Advisors LLC still held 101,654 shares as of 2016-12-31. Spears Abacus Advisors LLC reduced to the holdings in WisdomTree Europe SmallCap Dividend Fund by 68.25%. The sale prices were between $51.8 and $55.7, with an estimated average price of $53.47. The stock is now traded at around $57.54. The impact to the portfolio due to this sale was -0.15%. Spears Abacus Advisors LLC still held 9,895 shares as of 2016-12-31. Spears Abacus Advisors LLC reduced to the holdings in Vanguard FTSE Developed Markets by 45.18%. The sale prices were between $35.58 and $37.43, with an estimated average price of $36.47. The stock is now traded at around $38.40. The impact to the portfolio due to this sale was -0.14%. Spears Abacus Advisors LLC still held 34,590 shares as of 2016-12-31. Spears Abacus Advisors LLC reduced to the holdings in Goldman Sachs Group Inc by 64%. The sale prices were between $161.07 and $243.09, with an estimated average price of $203.06. The stock is now traded at around $246.90. The impact to the portfolio due to this sale was -0.08%. Spears Abacus Advisors LLC still held 2,040 shares as of 2016-12-31. Spears Abacus Advisors LLC reduced to the holdings in Bristol-Myers Squibb Company by 71.73%. The sale prices were between $49.23 and $59.61, with an estimated average price of $54.67. The stock is now traded at around $51.85. The impact to the portfolio due to this sale was -0.06%. Spears Abacus Advisors LLC still held 3,730 shares as of 2016-12-31. Spears Abacus Advisors LLC reduced to the holdings in Vanguard Information Tech ETF - DNQ by 38.78%. The sale prices were between $116.6 and $123.83, with an estimated average price of $120.57. The stock is now traded at around $131.34. The impact to the portfolio due to this sale was -0.05%. Spears Abacus Advisors LLC still held 5,350 shares as of 2016-12-31. This article first appeared on GuruFocus . The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings? Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.